期刊文献+

血液病血小板输注的治疗效果探究

Therapeutic Effect of Platelet Transfusion in Hematological Diseases
在线阅读 下载PDF
导出
摘要 目的分析评价血液病血小板输注的治疗效果。方法选择本院收治的99例血液病患者为研究主体。对其进行血小板输注治疗,对比输注前与输注后的治疗效果。结果输注1 h与24 h后的CCI和PPR均显著高于输注前(P<0.05)。体重>60 kg的输注有效率显著高于体重≤60 kg的输注有效率(P<0.05)。结论为血液病患者进行血小板输注治疗可取得较佳的治疗效果,应积极推广。 Objective To analyze and evaluate the therapeutic effect of platelet transfusion in hematological diseases. Methods Ninety-nine patients with hematological diseases admitted to our hospital were selected as the study subjects. Its platelet transfusion therapy,compared with the infusion before and after infusion of treatment. Results The CCI and PPR at 1 h and 24 h after infusion were significantly higher than those before infusion(P<0.05). The infusion efficacies of body weight>60 kg were significantly higher than those of body weight<60 kg(P<0.05). Conclusion Platelet transfusion therapy for patients with hematological diseases can achieve better therapeutic effect and should be actively promoted.
作者 张虎田
出处 《大医生》 2017年第10期122-123,共2页 Doctor
关键词 血液病 血小板输注 治疗效果 hematological diseases platelet transfusion therapeutic effect
  • 相关文献

参考文献4

二级参考文献34

  • 1尤建国,宣恒报,李玉峰,汪承亚.血液病患者机采血小板输注疗效及血小板抗体分析[J].中华血液学杂志,2007,28(9):635-636. 被引量:22
  • 2Sacher RA, Kicker TS, Schiffer CA, et al. Management of patients refractory to platelet transfusion [ J ]. Archiv Pathol Lab Med, 2003,127 (4) :409-414.
  • 3高峰.临床检验血液学[M].北京:人民卫生出版社,2003:149.
  • 4Rebulla P. Refractoriness to platelet transfusion [ J ]. Curt Opin Hematol, 2002,9(6) :516-520.
  • 5Davis KB, Slichter SJ, Corrash L. Corrected count increment and percent platelet recovery as measures of posttransfusion platelet re- sponse : problems and a solution [ J ]. Transfusion, 1999,39 ( 6 ) : 586-592 . .
  • 6Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the Ameri- can Society of Clinieal Oneology [ J ]. J Clin Oneol, 2007,19 ( 5 ) 1519-1538.
  • 7Alcorta I, Pereira A, Ordinas A, et al. Clinical and laboratory tac- tors assoeiated with transfusion refraetorieness a case-control study [ J ]. Br J Haematol, 1996, 93 ( 1 ) :220-224.
  • 8Miki H, Ozaki S, Tanaka O, et al. Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple mye- loma [ J ]. Int J Hematol, 2009, 89 (2) :223-226.
  • 9JIA Y, LI W, LIU N, et al. Prevalence of platelet- specific antibodies and efficacy of crossmatch-compatibleplatelet transfusions in refractory patients [ J ]. Transfus Med. 2014, 24(6) :406-410.
  • 10AGARWAL N, CHAqTERJEE K, SEN A, et al, Prevalence of platelet reactive antibodies in patient refractory to plate- lettransfusions[ J]. Asian J Transfus Sci, 2014,8 ( 2 ) : 126- 127.

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部